HomeRAPH • OTCMKTS
add
Raphael Pharmaceutical Inc
Previous close
$1.00
Year range
$0.23 - $1.65
Market cap
18.70M USD
Avg Volume
103.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 319.00K | -56.24% |
Net income | -326.00K | 55.03% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 40.00K | -86.62% |
Total assets | 51.00K | -87.34% |
Total liabilities | 667.00K | 39.54% |
Total equity | -616.00K | — |
Shares outstanding | 18.70M | — |
Price to book | -33.33 | — |
Return on assets | -891.06% | — |
Return on capital | 176.05% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -326.00K | 55.03% |
Cash from operations | -80.00K | 84.03% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -80.00K | -142.55% |
Free cash flow | 42.25K | 116.59% |
About
Founded
2007
Website
